Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - April 2010

The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines.

Metformin powder for oral solution (Glucophage®) has been accepted for restricted use in the treatment of type 2 diabetes mellitus in patients who are unable to swallow the solid dosage formulation.

Tacrolimus 0.03% ointment (Protopic®) has been accepted for restricted use as a maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in children experiencing a high frequency of disease exacerbations provided it is initiated by a dermatologists in secondary care.

Tacrolimus 0.1% ointment (Protopic®) has been accepted for restricted use for the maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in adult patients experiencing a high frequency of disease exacerbations provided it is initiated by a dermatologists in secondary care.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - April 2010' on Email Share 'SMC Update - April 2010' on Delicious Share 'SMC Update - April 2010' on Digg Share 'SMC Update - April 2010' on Facebook Share 'SMC Update - April 2010' on Google+ Share 'SMC Update - April 2010' on reddit Share 'SMC Update - April 2010' on StumbleUpon Share 'SMC Update - April 2010' on Twitter

atomic-wealth

No Comments to “SMC Update - April 2010”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,658 spam comments.

atomic-wealth
fond-illness
summer